319 results
Page 3 of 16
8-K
EX-99.1
w1yio brqw7txaez9r43
4 Aug 22
Amicus Therapeutics Announces Second Quarter 2022 Financial Results
7:01am
8-K
EX-99.1
dl8w4hucvz2 jog
10 May 22
Amicus Therapeutics Receives Notification of PDUFA Date Extensions for AT-GAA
4:01pm
8-K/A
EX-99.1
bu1iwpcnl45x wp0
9 May 22
Amicus Therapeutics Announces First Quarter 2022 Financial Results
12:54pm
8-K
EX-99.2
jc2 77eutq1
9 May 22
Amicus Therapeutics Announces First Quarter 2022 Financial Results
7:00am
8-K
EX-99.1
b4u4cc
9 May 22
Amicus Therapeutics Announces First Quarter 2022 Financial Results
7:00am
8-K
EX-99.1
u3rrt
24 Feb 22
Amicus Therapeutics Announces Full-Year 2021 Financial Results and Corporate Updates
7:00am
8-K
EX-99.2
ditl28tq8r 7ok
24 Feb 22
Amicus Therapeutics Announces Full-Year 2021 Financial Results and Corporate Updates
7:00am
8-K
EX-99.2
4cy4204m x5v71jw1
10 Jan 22
Amicus Therapeutics Reports Preliminary 2021 Revenue and Provides 2022 Strategic Outlook and Revenue Guidance
7:00am
8-K
EX-99.1
oio msj0jl
10 Jan 22
Amicus Therapeutics Reports Preliminary 2021 Revenue and Provides 2022 Strategic Outlook and Revenue Guidance
7:00am
8-K
EX-99.1
ki3gjkaq xpn
3 Dec 21
Other Events
7:00am
8-K
in7wtmp7
18 Nov 21
The Lancet Neurology Publishes Pivotal Phase 3 PROPEL Study Results of AT-GAA in Late-Onset Pompe Disease
7:01am
8-K
EX-99.1
e0lbf
18 Nov 21
The Lancet Neurology Publishes Pivotal Phase 3 PROPEL Study Results of AT-GAA in Late-Onset Pompe Disease
7:01am
8-K
EX-99.2
wlhe5
9 Nov 21
Amicus Therapeutics Announces Third Quarter 2021 Financial Results and Corporate Updates
7:07am
8-K
EX-99.1
6jxok 12v0
9 Nov 21
Amicus Therapeutics Announces Third Quarter 2021 Financial Results and Corporate Updates
7:07am
DEFA14A
yj4h05
29 Sep 21
Additional proxy soliciting materials
12:27pm
8-K
wr3wz
29 Sep 21
Amicus Therapeutics and ARYA Sciences Acquisition Corp IV
9:28am